NCT07431632 Intraoperative Cryoanalgesia Versus Thoracic Epidural Block in MIRPE (Minimally Invasive Repair of Pectus Excavatum)
| NCT ID | NCT07431632 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Sao Paulo |
| Condition | Funnel Chest |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-11-28 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-11-28 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this study is to compare epidural blockade with cryoanalgesia of the intercostal nerves as an analgesic method in the postoperative period of minimally invasive repair of pectus excavatum (MIRPE).
Eligibility Criteria
Inclusion Criteria: 1. Having pectus excavatum; 2. Having signed the Informed Consent Form for the study. Exclusion Criteria: 1. Age \< 13 years at the time of the procedure; 2. Chronic use of analgesics preoperatively; 3. Pectus carinatum, Poland syndrome, or other chest wall anomalies; 4. Previous pectus excavatum repair by any technique; 5. Previous thoracic surgery; 6. Congenital heart disease; 7. Hemorrhagic dyscrasia; 8. Major anesthetic risk factors or history of previous problems with anesthesia; 9. Pregnancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07431632 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, studying Funnel Chest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07431632 currently recruiting?
Yes, NCT07431632 is actively recruiting participants. Contact the research team at tedde@usp.br for enrollment information.
Where is the NCT07431632 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT07431632 clinical trial?
NCT07431632 is sponsored by University of Sao Paulo. The trial plans to enroll 40 participants.